Revenue
Margin
Demand
Guidance
Tone
Metrics cut 1
- Amirpur FY27 revenue guidance cut to ₹50-60 crores (from ₹70-80 crores previously)
Event Participants
Executives
2 Dheeraj Kumar Jain, Satya Prakash Gupta
Analysts
7 Karan Shah, Kaushal Sharma, Nitin Raheja, Saket Kapoor, Sucrit Patil, Vidhi Shah, Yogansh Jeswani
Financials & KPIs
| Metric | Reported | Commentary |
|---|---|---|
| Total Revenue | ₹256 crores | -9.2% YoY (₹282 crores in Q1 FY26); softer domestic demand for key herbicides |
| Revenue - Technical | ₹181 crores | Core technical segment, supported by regulatory compliance and complex off-patent manufacturing |
| Revenue - Formulation | ₹72 crores | Supported by 18-state network, 24 depots, 370+ sales professionals |
| Export Revenue | ₹89 crores | ~35% of total revenue; marginally above ₹87 crores YoY, exports resilient |
| Domestic Revenue | ₹167 crores | Down from ₹195 crores YoY; deficient rainfall led to non-sowing/delayed sowing |
| EBITDA | ₹39 crores | Margin 15.4% vs 18.4% YoY; lower volumes, higher employee cost, fuel, ₹2.5 cr write-off, ₹6 cr job work charges |
| PAT | ₹23 crores | PAT margin 8.9% vs 12.4% YoY (₹35 crores) |
| Cash Balance | ₹59 crores | Healthy balance sheet; capex funded through internal accruals, no term loans |
| Receivable Days | ~120 days | Stable QoQ |
| Inventory Days | ~200 days | Up from ~167-170 days due to lower sales against stock built; expected to fall to ~170 days by Q3 |
Geographic & Segment Commentary
- Domestic Market: Revenue at ₹167 crores, down from ₹195 crores YoY. Deficient and erratic rainfall impacted paddy sowing, hitting demand for Pretilachlor, the company's key herbicide. Management expects normalization in coming quarters as monsoon evolves.
- Exports: Revenue at ₹89 crores (~35% of total), slightly ahead of ₹87 crores YoY. Presence in 35+ countries with long-standing relationships with global agrochemical majors. EU technical equivalence approval for a fungicide expected to drive incremental export revenue from November.
- Technical vs Formulation: Technical revenue at ₹181 crores, formulation at ₹72 crores. Combined manufacturing capacity stands at 28,300 MT technical and 10,200 MT formulated products.
Company-Specific & Strategic Commentary
- EU Technical Equivalence Approval: Received TEQ approval from the European Union for a fungicide product. Existing annual revenue on this molecule is ~₹100 crores; approval enables adding new customers directly, with incremental ₹30-40 crores expected. Sales commencement from November after customer source approvals (1-2 months).
- New China-Import Fungicide: Small-scale production already started of a fungicide currently imported from China, with no significant Indian manufacturer. India imports ~4,000-5,000 tons annually; IPL targeting ~2,000 tons capacity at Sandila. Priced at ₹500-600/kg, primarily for domestic market.
- Amirpur Facility Expansion: 2 of 10 blocks operational; herbicide complex being prioritized (third block under commissioning, fourth under construction). Adding ~2 blocks per year targeting ~₹1,000 crores revenue in 3-4 years. Capex of ₹70-100 crores annually at Amirpur plus ₹25-30 crores at Sandila.
- Backward Integration & R&D: Intermediate plant developed using in-house indigenous R&D technology supports supply chain stability and reduces import dependence. DSIR-approved R&D facilities focused on process innovation, yield improvement and new molecule development.
Guidance & Outlook
| Metric | Guidance / Outlook | Commentary |
|---|---|---|
| FY27 Revenue Growth | Lower single digit | Q3 and Q4 expected to be better; monsoon erraticity is the key variable |
| EBITDA Margin | ~15.5% sustainable; ~18% if conditions improve | Q1 impacted by one-time write-off (₹2.5 cr) and higher job work (₹6 cr); 15-16% sustainable worst case |
| Amirpur Revenue (FY27) | ₹50-60 crores | New products manufacturing from end of current month; third block (herbicide) commissioning this year |
| Amirpur Revenue (3-4 years) | ~₹1,000 crores | Requires 8-10 production blocks; adding 2 blocks per year |
| New Fungicide Capacity | ~2,000 tons | Targeting domestic import substitution (~4,000-5,000 tons imported annually) |
| Inventory Days | ~170 days by Q3 | Normalizing as season demand picks up |
Risks & Constraints
| Risk | Context |
|---|---|
| Erratic Monsoon / Demand | Deficient and erratic rainfall caused delayed or damaged sowing, hitting Pretilachlor demand in Q1. Management acknowledges continued uncertainty for FY27 growth, with lower single-digit guidance. |
| Chinese Competition | Chinese products entering at significantly lower prices. Management responding via operational efficiency, R&D process optimization and reduced project costs. |
| Single-Molecule Dependence | Pretilachlor remains a key revenue driver; year-on-year volatility in star molecules. Mitigation: adding 3 products in FY27 (new fungicide, herbicide at Sandila, multi-purpose herbicide plant). |
| Inventory Buildup | Inventory days up to ~200 from ~167-170 due to lower sales against manufactured stock. Expected to normalize to ~170 days by Q3 as season demand picks up. |
Q&A Highlights
Execution Priorities & Competitive Risk
- Question: What are the top 2-3 execution priorities and biggest risks in coming quarters? (Sucrit Patil - Eyesight Fintrade)
- Answer: Two major priorities: strengthening manufacturing of a product currently imported from China, and building a multi-purpose herbicide plant at Amirpur. Chinese competition is the key challenge - responding via operational efficiency improvements and R&D process optimization. CFO added: no term loans planned; capex funded through internal accruals; raw material and finished goods prices have moderated. (Dheeraj Kumar Jain - CEO / Satya Prakash Gupta - CFO)
Margin Decline & One-Time Items
- Question: Why did operating margins decline despite good gross margins? Any one-off items? (Yogansh Jeswani - Mittal Analytics)
- Answer: Other expenses included ₹2.5 crores one-time write-off of export receivables and ~₹6 crores of higher job work charges for converting raw materials into intermediates in anticipation of higher Q1 sales, which were not consumed due to volume decline. Fuel costs were also higher. (Satya Prakash Gupta - CFO)
Demand Outlook & Pretilachlor
- Question: Are we seeing revival in Q2? How is Pretilachlor performing? (Yogansh Jeswani)
- Answer: Pretilachlor demand is subdued due to erratic rains - heavy rain damaged crops in some areas, shortfall in others delayed or destroyed sowing. IPL remains a major player in this molecule and expects normalization in coming quarters. Amirpur FY27 revenue revised to ₹50-60 crores, not the earlier ₹70-80 crores. (Dheeraj Kumar Jain - CEO)
New Fungicide Product Economics
- Question: How big is the new China-import product, who else manufactures it, can IPL match Chinese cost? (Yogansh Jeswani)
- Answer: No significant Indian manufacturer exists; IPL will be the major domestic producer. India imports 4,000-5,000 tons annually; IPL targeting 2,000 tons at ₹500-600/kg. Production at Sandila, primarily domestic, small quantities already being manufactured and test-marketed. (Dheeraj Kumar Jain - CEO)
Amirpur Capacity & Revenue Potential
- Question: Are you on track for ₹70-80 crores from Amirpur? What's the overall potential? (Kaushal Sharma - Equinox Capital)
- Answer: Expecting ₹50-60 crores from Amirpur in FY27. With 8-10 blocks (adding 2 per year), revenue of ~₹1,000 crores achievable in 3-4 years. Capex of ₹70-100 crores annually at Amirpur plus ₹25-30 crores at Sandila. Current capacity utilization ~70%. (Dheeraj Kumar Jain - CEO)
Margin Sustainability
- Question: What is sustainable EBITDA margin going forward? (Kaushal Sharma)
- Answer: 15.5% this quarter is sustainable. Targeting ~18% if conditions improve - geopolitical situation improving should help. Worst case, 15-16% is maintainable. (Dheeraj Kumar Jain - CEO)
Volume vs Price Mix & Product Pipeline
- Question: What's the volume vs price split on the revenue decline? How are you reducing molecule concentration risk? (Karan Shah - GeeCee Investments)
- Answer: Volume declined ~13% while price improved ~4%. Strategy: adding 3 products in FY27 (one already launched - new fungicide, one more herbicide at Sandila, plus multi-purpose herbicide plant for two products simultaneously) to reduce dependence on any single molecule. FY27 revenue guidance is lower single-digit growth. (Dheeraj Kumar Jain - CEO / Satya Prakash Gupta - CFO)
EU Approval & Export Growth
- Question: What opportunity does EU technical equivalence approval offer? What's the monetization timeline? (Saket Kapoor - Kapoor & Company)
- Answer: Existing annual revenue on this molecule is ~₹100 crores; EU approval enables adding new customers directly, incremental ₹30-40 crores expected. Sales likely commence from November after customer source approvals (1-2 months). Q1 exports already slightly ahead of last year. (Dheeraj Kumar Jain - CEO)
Key Takeaway
India Pesticides Ltd reported a soft Q1 FY27 with consolidated revenue of ₹256 crores (-9.2% YoY), EBITDA of ₹39 crores (15.4% margin vs 18.4% YoY) and PAT of ₹23 crores, dragged by erratic rainfall impacting Pretilachlor demand, a ₹2.5 crore export receivable write-off and ₹6 crores of advance job-work charges. Exports held steady at ₹89 crores (~35% of revenue) and the company secured EU technical equivalence approval for a fungicide, expected to add ₹30-40 crores of incremental export revenue from November. Strategy centers on reducing single-molecule concentration: a new China-substitution fungicide (2,000 ton capacity at Sandila, ~₹500-600/kg) and a multi-purpose herbicide plant at Amirpur, driving ₹50-60 crores from Amirpur in FY27 and a potential ₹1,000 crores in 3-4 years. Management guided lower single-digit FY27 revenue growth, 15.5% EBITDA margin as sustainable with an 18% target if conditions improve, and expects inventory days to normalize to ~170 by Q3. Watch points: monsoon trajectory, Chinese pricing pressure and execution of the Amirpur block roadmap.